Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy

Chin Med J (Engl). 2022 Jun 5;135(11):1383-1385. doi: 10.1097/CM9.0000000000002210.

Authors

Yicong Bian¹, Minzhou Huang², Sheng Ma¹, Linsheng Liu¹, Fan Xia¹, Zhiyao Chen¹, Di Yu¹, Chenrong Huang², Liyan Miao¹

Affiliations

¹ Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
² College of Pharmaceutical Science, Soochow University, Suzhou, Jiangsu 215000, China.

No abstract available

MeSH terms

Adenosine Triphosphate
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chemotherapy, Adjuvant
Humans
Stomach Neoplasms* / surgery
Taxoids / therapeutic use

Substances

Taxoids
Adenosine Triphosphate